Instil Bio Inc (TIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,133 | 21,764 | 27,350 | 43,716 | 41,118 |
| Marketable Securities | 174,315 | 179,935 | 195,845 | 217,204 | 262,169 |
| Other current assets | 1,600 | 6,432 | 7,619 | 0 | 0 |
| TOTAL | $195,630 | $220,587 | $240,121 | $269,378 | $313,656 |
| Non-Current Assets | |||||
| PPE Net | 139,435 | 181,469 | 180,010 | 196,880 | 185,057 |
| Intangibles | 0 | 0 | 0 | 0 | 15,826 |
| Other Non-Current Assets | 5,207 | 6,254 | 7,041 | 15,870 | 18,202 |
| TOTAL | $144,642 | $187,723 | $187,051 | $212,750 | $219,085 |
| Total Assets | $340,272 | $408,310 | $427,172 | $482,128 | $532,741 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,645 | 2,160 | 1,349 | 2,359 | 5,328 |
| Accrued Expenses | 11,822 | 16,097 | 25,217 | 30,069 | 36,361 |
| Other current liabilities | N/A | 120 | 123 | 360 | 412 |
| TOTAL | $13,467 | $18,377 | $26,689 | $32,788 | $42,101 |
| Non-Current Liabilities | |||||
| Long Term Debt | 81,178 | 81,516 | 77,065 | 72,350 | 62,974 |
| Other Non-Current Liabilities | 11,603 | 11,901 | 12,264 | 13,385 | 16,523 |
| TOTAL | $92,781 | $93,417 | $89,329 | $85,735 | $80,052 |
| Total Liabilities | $106,248 | $111,794 | $116,018 | $118,523 | $122,153 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,504 | 6,504 | 6,504 | 6,504 | 6,489 |
| Retained earnings | -568,056 | -500,624 | -481,962 | -424,894 | -371,050 |
| Other shareholders' equity | -525 | -795 | -406 | -493 | -335 |
| TOTAL | $234,024 | $296,516 | $311,154 | $363,605 | $410,588 |
| Total Liabilities And Equity | $340,272 | $408,310 | $427,172 | $482,128 | $532,741 |